Seattle-based startup KenSci, which offers an AI-powered risk prediction platform, has raised $22 million in a Series B round led by Polaris Partners. Ignition Partners, Osage University Partners, Mindset Ventures and UL Ventures also participated.
The company, which also has offices in Singapore and Hyderabad, India, will use the funding to accelerate its product roadmap and global expansion plans. It also intends to bolster its relationships with health systems.
KenSci was incubated at the University of Washington’s Center for Data Science at UW Tacoma. Its platform brings in data from various sources — EMRs, claims, pharmacies and wearables, to name a few — to pinpoint patterns that help health systems assess risks related to care, costs and operations. The startup’s machine learning platform can also integrate into a system’s existing workflows.
Organizations can use KenSci’s tool for chronic kidney disease prediction, sepsis prediction, claims denial prediction, emergency department utilization prediction and more.
The startup’s clients include Rush University Medical Center and Madigan Army Medical Center.
“In the last two years, we’ve singularly invested ourselves in building a platform that simplifies the way health systems look at their data and gain actionable, predictive insights to save lives and costs,” KenSci co-founder and CEO Samir Manjure said in a statement. “With this round of funding, we’re excited to take these capabilities to a global stage with partners who complement our capabilities and are committed to helping us drive this transformation across the care continuum.”
The startup has raised a grand total of $30.5 million. In 2017, it raked in $8.5 million in a Series A round led by Ignition Partners. Osage University Partners and Mindset Ventures participated as well.
Photo: AlisLuch, Getty Images